Mild cognitive impairment (MCI) is the prodromal stage of Alzheimer’s disease (AD). Identifying MCI subjects who are at high risk of converting to AD is crucial for effective treatments. In this study, a deep learning approach based on convolutional neural networks (CNN), is designed to accurately predict MCI-to-AD conversion with magnetic resonance imaging (MRI) data. First, MRI images are prepared with age-correction and other processing. Second, local patches, which are assembled into 2.5 dimensions, are extracted from these images. Then, the patches from AD and normal controls (NC) are used to train a CNN to identify deep learning features of MCI subjects. After that, structural brain image features are mined with FreeSurfer to assist CNN. Finally, both types of features are fed into an extreme learning machine classifier to predict the AD conversion. The proposed approach is validated on the standardized MRI datasets from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) project. This approach achieves an accuracy of 79.9% and an area under the receiver operating characteristic curve (AUC) of 86.1% in leave-one-out cross validations. Compared with other state-of-the-art methods, the proposed one outperforms others with higher accuracy and AUC, while keeping a good balance between the sensitivity and specificity. Results demonstrate great potentials of the proposed CNN-based approach for the prediction of MCI-to-AD conversion with solely MRI data. Age correction and assisted structural brain image features can boost the prediction performance of CNN.
Accelerated multi-dimensional NMR spectroscopy is a prerequisite for high-throughput applications, studying short-lived molecular systems and monitoring chemical reactions in real time. Non-uniform sampling is a common approach to reduce the measurement time. Here, a new method for high-quality spectra reconstruction from nonuniformly sampled data is introduced, which is based on recent developments in the field of signal processing theory and uses the so far unexploited general property of the NMR signal, its low rank. Using experimental and simulated data, we demonstrate that the low-rank reconstruction is a viable alternative to the current state-of-the-art technique compressed sensing. In particular, the low-rank approach is good in preserving of lowintensity broad peaks, and thus increases the effective sensitivity in the reconstructed spectra.
This paper explores robust recovery of a superposition of R distinct complex exponential functions with or without damping factors from a few random Gaussian projections. We assume that the signal of interest is of 2N − 1 dimensions and R < 2N − 1. This framework covers a large class of signals arising from real applications in biology, automation, imaging science, etc. To reconstruct such a signal, our algorithm is to seek a low-rank Hankel matrix of the signal by minimizing its nuclear norm subject to the consistency on the sampled data. Our theoretical results show that a robust recovery is possible as long as the number of projections exceeds O(Rln2
N). No incoherence or separation condition is required in our proof. Our method can be applied to spectral compressed sensing where the signal of interest is a superposition of R complex sinusoids. Compared to existing results, our result here does not need any separation condition on the frequencies, while achieving better or comparable bounds on the number of measurements. Furthermore, our method provides theoretical guidance on how many samples are required in the state-of-the-art non-uniform sampling in NMR spectroscopy. The performance of our algorithm is further demonstrated by numerical experiments.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.